// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Asthma reviews in primary care which include spirometry lead to improved asthma control in children

David Lo - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The role of mobile apps in allergic respiratory diseases: an italian survey report

Carlo Lombardi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The utility of CURB-65 scoring in the acute management of radiologically proven pneumonia

Pradeep Mallisetty - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension

Laura Price - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Sildenafil citrate

Do predicted tidal volumes have value in setting up domiciliary non-invasive ventilation?

Sara Parsons - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Disease control and treatment pathways of asthma patients after initiating ICS/LABA

Roland Buhl - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study

Katerina Antoniou - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nintedanib

Influence of the VitaBreath on Exercise Tolerance in Patients with COPD

Nikolaos Chykiamis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Using a Bayesian approach and external validation to predict persistent asthma at the age of 10 and 20 years in general and high-risk populations

Silvia Colicino - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Asthma

N/A

A randomised placebo-controlled dose finding study of tobramycin inhalation powder (TIP) in patients with bronchiectasis (BE) and pulmonary P. aeruginosa Pa) infection (iBEST-1)

Michael Loebinger - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I

Catherine Billings - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Late Breaking Abstract - Blood eosinophil counts and treatment response in COPD: analyses of IMPACT

Steven Pascoe - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Fluticasone furoate

Severe mental illness in COPD patients: findings from the primary care 2015-17 COPD audit

Gerasimina Garnavos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Schizophrenia

N/A

Survival in medically treated chronic thromboembolic pulmonary hypertension patients

Marion Delcroix - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma

Paul O'Byrne - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Terbutaline

Oxygen wristbands, a visual aid to aid patient safety

Jaclyn Proctor - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The relationship between diaphragmatic mobility and chest wall expansion in cerebral palsy

Nittaya Tanrangka - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral Palsy

N/A

Body mass index trajectories during adult life and lung function decline

Gabriela P. Peralta - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

The Relationship between Fractional exhaled nitric oxide (FeNO) and Asthma Control and Asthma Severity in Asthmatic Adults in Vietnam

Vinh Nguyen Nhu - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Is there a need for Vedio-assisted Thoracoscopic surgical (VATS) pleural biopsy following a Medical Thoracoscopy (MT)?

Mohamed Akram Abdulla - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved